Loading…

Regulatory issues for commercialization of tomatoes with an antisense polygalacturonase gene

Significant progress has been made in development of transgenic plants containing agriculturally useful genes. Concurrent with scientific advances has been development of a regulatory infrastructure within the U.S. Department of Agriculture (USDA) for assessing safety of controlled release of geneti...

Full description

Saved in:
Bibliographic Details
Published in:In vitro cellular & developmental biology. Plant 1993-01, Vol.29P (1), p.17-26
Main Authors: Redenbaugh, K, Berner, T, Emlay, D, Frankos, B, Hiatt, W, Houck, C, Kramer, M, Malyj, L, Martineau, B, Rachman, N
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Significant progress has been made in development of transgenic plants containing agriculturally useful genes. Concurrent with scientific advances has been development of a regulatory infrastructure within the U.S. Department of Agriculture (USDA) for assessing safety of controlled release of genetically engineered plants into the environment, as well as creation of a food policy by the Food and Drug Administration (FDA). Field trials and safety assessments of tomato containing an antisense polygalacturonase gene (FLAVR SAVR)[TRADE MARK] tomato) have been conducted. A detailed safety analysis of the kanrselectable marker was also done. Based on these data plus nutritional measurements, lack of changes in levels of natural toxins, and lack of any unintended changes, we have requested that the USDA and FDA determine that this genetically engineered tomato is safe for release into the environment and human consumption.
ISSN:1054-5476
1475-2689
DOI:10.1007/BF02632234